Mayo Foundation for Medical Education and Research patent applications published on March 21st, 2024

Summary of the patent applications from Mayo Foundation for Medical Education and Research on March 21st, 2024

The Mayo Foundation for Medical Education and Research has recently filed patents related to the treatment of congenital diseases, cancer, and gut microbiota dysbiosis. These patents involve methods and materials for treating congenital diseases in mammals by using nucleic acids to suppress mutant disease-related alleles and provide replacement cDNA. Another patent focuses on compounds for treating cancer, specifically targeting cancer cells with novel compounds. Additionally, a patent discusses biomarkers for predicting gut microbiota dysbiosis and compositions to restore healthy gut microbiota, potentially treating Clostridium difficile infection (CDI).

Summary of notable applications:

• Treatment of congenital diseases in mammals using nucleic acids
• Development of new cancer treatments with novel compounds
• Prediction of gut microbiota dysbiosis and potential treatment of CDI

These patents demonstrate innovative approaches to addressing various medical conditions, offering potential benefits in improving patient outcomes and quality of life.

Patent applications for Mayo Foundation for Medical Education and Research on March 21st, 2024

SURGICAL GOWNS (18524497)

Main Inventor

Salim M. Walji

System and Method for Non-Invasive Determination of Bladder Overactivity Using Ultrasound Vibrometry (18261622)

Main Inventor

Mostafa Fatemi

TREATMENT OF POLYCYSTIC DISEASES WITH AN HDAC6 INHIBITOR (18307559)

Main Inventor

Sergio A. Gradilone

METHODS AND MATERIALS FOR USING BIOMARKERS WHICH PREDICT SUSCEPTIBILITY TO CLOSTRIDIUM DIFFICILE INFECTION (18518183)

Main Inventor

Purna C. Kashyap

Proteasome Inhibitors (17768199)

Main Inventor

Asher Alban Akmal Chanan-Khan

Suppression-Replacement Gene Therapy (18270014)

Main Inventor

Michael J. ACKERMAN